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ABSTRACT   
Background: Cardiac adaptation to aortic stenosis (AS) appears to differ according to sex but reverse 
remodeling following aortic valve replacement has not been extensively described. The aim of the 
study was to determine using cardiac magnetic resonance (CMR) imaging, whether any sex-related 
differences exist in AS in terms of left ventricular (LV) remodeling, myocardial fibrosis and reverse 
remodeling after valve replacement. 
Methods: One hundred patients (men, n=60) with severe AS undergoing either trans-catheter or 
surgical aortic valve replacement underwent CMR scans at baseline and 6m following valve 
replacement.   
Results: Despite similar baseline co-morbidity and severity of AS, women had a lower indexed LV mass 
than men (65.3± 18.4 vs. 81.5±21.3g/m2, p<0.001) and a smaller indexed LV end diastolic volume 
(87.3±17.5 vs. 101.2±28.6ml/m2, p=0.002) with a similar LV ejection fraction (LVEF) (58.6±10.2 vs. 
54.8±12.9%, p=0.178). Total myocardial fibrosis mass was similar between sexes (2.3±4.1 vs. 1.3±1.1g, 
p=0.714) albeit with a differing distribution according to sex. Following aortic valve replacement, men 
had more absolute LV mass regression than females (18.3±10.6 vs. 12.7±8.8g/m2, p=0.007). When 
expressed as a percentage reduction of baseline indexed LV mass, mass regression was similar 
between the sexes (men 21.7±10.1 vs. women 18.4±11.0%, p=0.121).  There was no sex-related 
difference in post-procedural LVEF or aortic regurgitation. Sex was not found to a predictor of LV 
reverse remodelling on multiple regression analysis.   
Conclusions: There are significant differences in the way that male and female hearts adapt to AS. 6m 
following aortic valve replacement, there are no sex-related differences in reverse remodeling, but 
superior reverse remodeling in men as a result of their more adverse remodeling profile at baseline. 
Key words: Aortic Valve Stenosis, Sex, Hypertrophy, Heart Valve Prosthesis Implantation, Aortic 
Valve Disease, Gender  
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ABBREVIATIONS 
AR Aortic regurgitation 
AS Aortic stenosis 
AVAi Indexed aortic valve area 
AVR Aortic valve replacement 
BSA Body surface area 
CABG Coronary artery bypass grafting 
CMR Cardiac magnetic resonance 
COPD Chronic obstructive pulmonary disease 
EuroSCORE European System for Cardiac Operative Risk Evaluation 
LA Left atrial 
LAVoli Indexed left atrial volume 
LGE Late gadolinium enhancement 
LV Left ventricular 
LVEDVi Indexed left ventricular end diastolic volume 
LVEF Left ventricular ejection fraction 
LVESVi Indexed left ventricular end systolic volume 
LVMi Indexed left ventricular mass 
MF Myocardial fibrosis 
MR Mitral regurgitation 
NYHA New York Heart Association 
RF Regurgitant fraction 
SAVR Surgical aortic valve replacement 
SD Standard deviation 
SSFP Standard steady-state free procession 
TAVR Trans-catheter aortic valve replacement 
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INTRODUCTION 
Sex related differences in left ventricular (LV) remodeling in response to a wide range of diseases have 
been extensively explored1, but the impact of sex on aortic stenosis (AS) and following aortic valve 
replacement (AVR) is less well described. AS is the commonest valve lesion in the developed world, 
and with an ageing population its incidence is increasing2. AVR has been shown to reduce mortality, 
and improve patient symptoms and health related quality of life3-5. Evidence suggests that women 
have higher pre-operative morbidity and mortality6, and lower referral rates7. It remains controversial 
as to whether sex impacts on survival following surgical aortic valve replacement (SAVR)8, however, 
females appear to have improved long term survival following trans-catheter aortic valve replacement 
(TAVR)8-10. The longer life expectancy of women or other factors such as LV remodeling and myocardial 
fibrosis (MF) may be implicated. Echocardiographic and Cardiac Magnetic Resonance (CMR) studies 
suggest that men and women remodel differently to the pressure overload of AS11, 12 and may also 
reverse remodel differently following AVR13, 14. CMR imaging is the reference standard for LV mass and 
volume quantitation, with low intra-observer and inter-study variability. Moreover, sex-related 
differences in MF may play a key role in any reverse remodeling15. This can be accurately quantified 
non-invasively using the CMR late gadolinium enhancement (LGE) technique. The primary aim of this 
study was to determine whether any sex-related differences exist in severe AS in terms of LV 
remodeling, reverse remodeling after valve replacement and MF. 
METHODS 
Between January 2009 and April 2014, 135 patients (men, n=79 (59%), mean age 77±8 ) with severe 
AS undergoing either SAVR with or without concomitant coronary artery bypass grafting (CABG) or 
TAVR at a single tertiary centre (Leeds General Infirmary, Leeds, UK) were prospectively recruited 
(Figure 1). Severe AS was defined as an echocardiographically ĚĞƌŝǀĞĚĂŽƌƚŝĐǀĂůǀĞĂƌĞĂŽĨч ? ? ?cm2, 
peak aortic velocity of >4m/sec or mean pressure gradient of >40mmHg16. Decision for aortic valve 
intervention was made by the multi-disciplinary heart team in accordance with international 
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guidelines 17. Patients with contraindications to CMR were excluded. All patients provided written 
informed consent. The study was approved by the institutional ethics committee and complied with 
the declaration of Helsinki. This study was part-funded by the National Institute for Health Research 
Leeds Clinical Research Facility. The authors are solely responsible for the design and conduct of this 
study, all study analyses, the drafting and editing of the paper and its final contents. 
 
Figure 1. Patient recruitment pathway. SAVR: surgical aortic valve replacement, TAVR: Trans-
catheter aortic valve replacement.  
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Aortic valve replacement 
SAVR was performed in a standard manner on cardiopulmonary bypass via a midline sternotomy 
incision and mild systemic hypothermia using intraoperative transesophageal echocardiography 
guidance. Following standard heparinization the aorta was cross-clamped and cardiopulmonary 
bypass was initiated. The size and type of prosthesis was chosen according to annulus size, patient 
characteristics, surgical and patient preference. Concomitant coronary artery bypass was performed 
where indicated. TAVR was performed under general anaesthetic with X-ray fluoroscopy and TEE 
guidance using the self-expanding Medtronic CoreValve (Medtronic Inc., Minneapolis, Minnesota) or 
the mechanically expanded Boston Lotus valve (Boston Scientific Corporation, Natick, MA) via the 
femoral or subclavian route by two experienced, high-volume operators. All patients received heparin 
to maintain an activated clotting time >250s and were treated with dual anti-platelet therapy (aspirin 
and clopidogrel) for 3-6 months post-procedure.  
CMR protocol 
Identical CMR scans were obtained on the same imaging platform at baseline and at a median of 6 
months (Q1-Q3 5-6 months) following aortic valve replacement using a 1.5T scanner (Intera, Philips 
Healthcare, Best, Netherlands or Avanto, Siemens Medical Systems, Erlangen, Germany). Multi-slice, 
multi-phase cine imaging was performed using a standard steady-state free procession (SSFP) pulse 
sequence in the short axis (8mm thickness, 0mm gap, 30 phases, typical field of view 340mm) to cover 
both ventricles. Standard 4 chamber long axis and 2 chamber SSFP cine images were also acquired for 
measurement of atrial volume. Through-plane velocity encoded phase contrast (VENC) imaging was 
performed perpendicular to the aortic valve jet at the aortic sinotubular junction (VENC 250-
500cm/sec, retrospective gating, slice thickness 6mm, 40 phases). LGE imaging (10-12 short axis slices, 
10mm thickness, matrix 240x240) was performed with inversion time (TI) individually adjusted 
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according to TI scout, 10-15 minutes after the administration of 0.2mmol/kg of gadoteric acid 
(Dotarem, Guerbet, Villepinte). 
CMR analysis 
CMR analysis was performed by a single operator (LED) with 5 ǇĞĂƌƐ ?ĞǆƉĞƌŝĞnce in CMR blinded to 
clinical data. Endocardial and epicardial borders were manually contoured at end-diastole and end-
systole with papillary muscles and trabeculations excluded to allow the calculation of ventricular 
volumes (summation of discs methodology) and mass (epicardial volume  ? endocardial volume 
multiplied by myocardial density (1.05g/cm3)).. Values were indexed to body surface area (BSA). For 
analysis of the LGE images, each slice was visually inspected for the presence or absence of LGE, which 
was then categorised as either infarct pattern or focal/mid-wall pattern. In those slices  positive for 
LGE, automated quantification was performed using dedicated computer software (cmr42, Circle 
Cardiovascular Imaging Inc, Calgary, Alberta, Canada) using a threshold of 5 standard deviations 
method18. Left atrial area and length at end-systole was measured in the 4 chamber and 2 chamber 
cine views and a volume calculated based on the biplane area-length method19. Maximal septal and 
lateral wall thickness were measured at end diastole on the mid-ventricular short axis cine using 
electronic calliper measurement tools. Aortic flow was quantified using cross-sectional VENC images 
with contouring of the aortic lumen to provide a regurgitant fraction (%). Significant aortic 
regurgitation was defined as a regurgitant fraction >16%20. Mitral regurgitant fraction (%) was 
calculated using the equation: (LV stroke volume ?aortic stroke volume/LV stroke volume*100. 
Significant mitral regurgitation was defined as a regurgitant fraction >40%21. The intraclass correlation 
(ICC) for LGE quantification was 0.995 for intraobserver variability and 0.979 for interobserver 
variability.  
 
Statistical analysis 
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All statistical analyses were performed using the PASW software package (V21, SPSS, IBM, Chicago, 
Illinois, USA). Data are presented as mean±SD, median (Q1-Q3) or frequency (percentage). After 
testing for normality using the Shapiro-Wilks test, differences between means were evaluated using 
paired and unpaired (for independent group comparisons) Students t test for normally distributed 
data and the Mann Whitney or Wilcoxon signed rank test on non-parametric data.  The Chi-squared 
test was used for comparing categories of data. Pearson correlation coefficients were used to 
investigate the relationship of aortic regurgitation to baseline cardiac remodeling. A two sided P<0.05 
was considered statistically significant. Linear regression analysis was used to identify the main 
predictors of LV reverse remodeling and to derive parameter estimates for those predictors and for 
the differences in sex.  Univariate regression analysis was performed using baseline measurements 
entered as covariate factors. All clinically significant variables and those with a p<0.1 on univariate 
analysis were subject to exploratory analysis to exclude those with weak or no correlation with the 
dependent variable, before entering them into a stepwise multiple linear regression model to identify 
the main predictor or combination of predictors in a multivariable model.  
RESULTS 
Study participants 
135 patients were recruited into the study. 60 men and 40 women with severe AS completed both 
baseline and 6-month post-procedure CMR scans. Reasons for non-completion were varied and are 
depicted in Figure 1. There was no significant difference between the group that completed the 6 
month CMR protocol and those that did not in terms of age (77±7 vs. 79±7yrs, p=0.267), baseline 
indexed aortic valve area (AVAi) (0.35±0.09 vs. 0.35±0.10cm/m2, p=0.928), and European System for 
Cardiac Operative Risk Evaluation (EuroSCORE) II (4.04±4.27vs.4.96±3.60, p=0.257) indicating that the 
demographics of the analysed patients were representative of the larger population. Baseline 
demographic, clinical and echocardiographic characteristics of the final study population can be seen 
in Table 1.    
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 Total 
(n=100) 
Men 
(n=60) 
Women 
(n=40) 
P value 
for sex 
difference 
Age at intervention, years 77. ± 8 75 ± 7 80±9 0.004 
Length of stay, days 8.3±4.7 7.9±3.0 8.8±6.5 0.883 
BSA, m2 1.86 ± 0.2 1.96 ± 0.18 1.71 ± 0.16 <0.001 
Systolic blood pressure, mmHg 131 ± 23 129 ± 22 134 ± 24 0.20 
NYHA (median ) 2.9 ± 0.6, (3) 2.9 ± 0.6 (3) 3.0 ± 0.6 (3) 0.724 
EuroSCORE II, % 4.0 ± 4.3 3.9 ± 3.7 4.5 ± 5.1 0.340 
Hypertension 55 (55) 31 (52) 24 (60) 0.412 
Hypercholesterolemia 67 (67) 44 (73) 23 (57.5) 0.10 
Diabetes 21 (21) 11 (18) 10 (25) 0.42 
Atrial Fibrillation 19 (19) 13 (22) 6 (15) 0.41 
Previous myocardial infarction 15 (15) 9 (15) 6 (15) 1 
Previous CABG 19 (19) 14 (23) 5 (12.5) 0.176 
Any epicardial coronary artery stenosis 
>50% 
53 (53) 38 (63) 15 (38) 0.011 
Pulmonary hypertension 24 (24) 15 (25) 9 (22.5) 0.774 
Peripheral vascular disease 16 (16) 11 (18) 5 (12.5) 0.436 
Cerebrovascular disease 15 (15) 11 (18) 4 (10) 0.253 
COPD 16 (16) 13 (22) 3 (7.5) 0.058 
Indexed aortic valve area, cm/m2 0.35 ± 0.09 0.35 ± 0.09 0.35 ± 0.10 0.928 
Peak aortic velocity, m/sec 4.6±0.6 4.6±0.5 4.6±0.6 0.838 
Mean pressure gradient, mmHg 48±13 48±12 49±14 0.974 
Table 1. Baseline demographic, clinical and echocardiographic characteristics. BSA: Body surface area. 
BMI: Body mass index. NYHA: New York Heart Association classification. CABG: Coronary artery bypass 
grafting. COPD: Chronic obstructive pulmonary disease.  
 
Baseline CMR left heart measurements 
At baseline, women with severe AS had lower indexed LV mass (LVMi) than men (65.3± 18.4 vs. 
81.5±21.3g/m2, p<0.001) alongside smaller indexed LV end diastolic (LVEDVi) (87.3±17.5 vs. 
101.2±28.6ml/m2, p=0.002) and end systolic (LVESVi) (37.3±16.6 vs. 47.9±25.6ml/m2, p=0.036) 
volumes. A typical example of the different patterns of remodeling can be seen in Figure 2. Further 
baseline differences according to sex can be seen in Table 2.  Men had more aortic regurgitation (AR) 
at baseline (regurgitant fraction (RF) men 15.1±12.4 vs. women 9.6±9.2%, p=0.013). Significant AR at 
baseline was seen in 23 (38%) men and 7 (18%) women (p=0.026).  There was a significant correlation 
10 
 
between baseline LVMi and AR fraction in men (r=0.455, p<0.01) and in women (r=0.577, p<0.001). 
There was also a relationship between AR fraction and LVEDVi in men (r=0.433, p<0.001), but not in 
women (r=0.140, p=0.400). When those with significant baseline AR were excluded, men still had 
greater LVMi than women (LVMi men 77.1±16.5 vs. women 61.9±13.8g/m2, p=<0.001).  Mitral 
regurgitation (MR) was similar for both sexes (RF men 33.8±19.8 vs. women 26.9±21.3%, p=0.09). 
Significant mitral regurgitation was seen in 24 (40%) men and 10 (25%) women at baseline (p=0.121).   
Baseline mitral regurgitant fraction was significantly associated with baseline LVMI and LVEDVi on 
univariate analysis, but was not found to be an independent predictor of baseline remodelling on 
multivariate analysis (Supplementary Table 1). Sex and baseline aortic and mitral regurgitation fraction 
were univariate predictors of baseline LVMi and baseline LVEDVi (Supplementary Table 1). Sex and 
baseline AR remained independent predictors of baseline LVMi on multiple regression analysis. Only 
baseline AR fraction was an independent predictor of baseline LVEDVI (Supplementary Table 2). 
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Figure 2. Short axis and 4 chamber cardiac magnetic resonance  images of the left ventricle acquired 
at end diastole. The left sided panel depicts the typical female ventricle in severe aortic stenosis with 
a lower left ventricular (LV) mass and a small LV cavity size (top image) and subsequent LV mass 
regression 6 months (bottom image).  The right hand panel shows a typical male pattern of 
remodeling with increased LV cavity size and greater LV mass at baseline (top image) and then 
reverse remodeling 6 months following valve replacement (bottom image). Both male and female 
ventricles exhibit reverse remodeling with LV mass regression 6 months following valve 
replacement.  
 Total  
n=100 
Men  
n=60 
Women  
n=40 
P Value for  
sex difference 
LVMi, g/m2 
Pre-intervention 
Post-intervention 
 
75.1± 21.6 
59.0±15.9 
 
81.5±21.3 
63.2±15.8 
 
65.3±18.4 
52.6±14.0 
 
<0.001 
<0.001 
P Value  <0.001 <0.001 <0.001  
LVM/LVEDV 
Pre-intervention 
Post-intervention 
 
0.80±0.16 
0.69±0.15 
 
0.82±0.15 
0.72±0.15 
 
0.76±0.17 
0.65±0.14 
 
0.068 
0.006 
P Value <0.001 <0.001 <0.001  
Septal thickness, mm 
Pre-intervention 
Post-intervention 
 
12.2±3.1 
10.5±2.7 
 
13.3±2.8 
11.2±2.6 
 
10.5±2.8 
9.3±2.5 
 
<0.001 
<0.001 
P Value <0.001 <0.001 <0.001  
Lateral wall thickness, mm 
Pre-intervention 
Post-intervention 
 
8.0±2.2 
7.0±1.9 
 
8.6±2.1 
7.8±1.8 
 
7.1±2.1 
5.9±1.6 
 
<0.001 
<0.001 
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P Value <0.001 0.001 <0.001  
Septal:Lateral wall thickness ratio 
Pre-intervention 
Post-intervention 
 
1.58±0.41 
1.57±0.47 
 
1.56±0.36 
1.49±0.38 
 
1.55±0.48 
1.68±0.58 
 
0.458 
0.174 
P Value 0.314 0.020 0.270  
LVEDVi, ml/m2 
Pre-intervention 
Post-intervention 
 
    95.6 ±25.6 
86.5±20.7 
 
101.2±28.6 
89.6±21.2 
 
87.3±17.5 
81.9±19.2 
 
0.020 
0.075 
P Value <0.001 <0.001 0.019  
LVESVi, ml/m2 
Pre-intervention 
Post-intervention 
 
43.7±23.0 
37.9±17.1 
 
47.9±25.6 
40.1±17.1 
 
37.3±16.6 
34.4±16.9 
 
0.036 
0.045 
P Value <0.001 <0.001 0.088  
LVEF, % 
Pre-intervention 
Post-intervention 
 
56.4±12.1 
58.0±10.8 
 
54.8±12.9 
56.5±10.5 
 
58.6±10.6 
60.2±11.0 
 
0.177 
0.042 
P value 0.021 0.093 0.129  
LA Voli, ml/m2 
Pre-intervention 
Post-intervention 
 
67.2±20.8 
62.3±20.9 
 
67.8±21.8 
60.1±20.5 
 
66.2±19.3 
65.7±21.3 
 
0.578 
0.136 
P Value <0.001 <0.001 0.477  
Absolute myocardial fibrosis mass (g) 
Pre-intervention 
Post-intervention 
 
2.0±3.3 
1.6±3.9 
 
2.3±4.1 
2.3±4.7 
 
1.3±1.1 
0.4±0.8 
 
0.714 
0.034 
P value 0.022 0.412 0.010  
Myocardial fibrosis (% LV mass)  
Pre-intervention 
Post-intervention 
 
1.2±1.5 
1.2±2.4 
 
1.2±1.8 
1.6±2.9 
 
1.2±1.1 
0.5±0.9 
 
0.435 
0.114 
P Value 0.263 0.716 0.026  
Aortic maximum pressure gradient, 
mmHg 
Pre-intervention 
Post-intervention 
 
 
42±36 
21±12 
 
 
46±43 
21±11 
 
 
36±16 
20±13 
 
 
0.171 
0.323 
P value <0.001 <0.001 <0.001  
Table 2.  Cardiac magnetic resonance data pre and post intervention grouped according to sex. 
LVMi: Indexed left ventricular mass. LVEDVi: Indexed left ventricular diastolic volume. LVESVi: 
Indexed left ventricular end systolic volume. LVEF: Left ventricular ejection fraction. LA Voli: Indexed 
left atrial volume. LV: Left ventricular.  
 
Post-valve replacement  
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There was a similar length of post-procedure hospital stay between sexes (men 8±3 vs. women 
9±7days, p=0.883). Reverse remodeling parameters according to sex can be seen in Table 2 and Figure 
3. Following valve replacement there was a significant reduction in LVMi in both groups. Men 
experienced greater absolute LV mass regression than women (18.3±10.6 vs. 12.7±8.8g/m2, p=0.007), 
however, when expressed as a percentage reduction of baseline LVMi, mass regression was similar 
between the sexes (men 21.7±10.1 vs. women 18.4±11.0%, p=0.121). A sex-related difference in LVMi 
regression was still evident when those with significant baseline AR were excluded from the analysis 
(men 16.2±10.4 vs. women 11.4±8.2g/m2, p=0.034).  
 
Figure 3.  Values according to sex pre and post aortic valve replacement. Boxplots show median 
values (line within box), 50th percentile values (box outline) and maximum and minimum values 
(whiskers).  LVMi: Indexed left ventricular mass. LVEF: Left ventricular ejection fraction. LAVOLi: 
Indexed left atrial volume. LVEDVi: Indexed left ventricular end diastolic volume. LVESVi: Indexed left 
ventricular end systolic volume.  
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There was no sex-related difference in post-procedural AR (RF men 8.4±8.0% vs women 6.9±6.8%, 
p=0.406). Significant post-procedural AR was seen in 9 (15%) men and 4 (10%) of women (p=0.347). 
Men experienced a significant reduction in MR following valvular intervention whereas women did 
not (men 33.8±19.8 to 17.6±18.1%, p<0.001, women: 26.9±21.3 to 20.5±19.6%, p=0.102). Significant 
post-procedural MR was seen in 5 (8%) of men and 6 (15%) women (p=0.297).  
Results according to sex and procedure type can be seen in supplementary Table 3.  
Myocardial fibrosis 
LGE imaging was available for 95 patients. 5 patients (male, n=4) were not given a Gadolinium-based 
contrast agent due to pre-existing renal failure with an estimated glomerular filtration rate of 
<30ml/min/1.73m2. Patients were classified at baseline according to whether they had no LGE (men 
n=14 (25%), women n=16 (41%)), infarct pattern LGE (men n=14 (25%), women n=7 (18%)) or mid-
wall/focal fibrosis pattern LGE (men n=28 (50%), women 16 (41%)).   
The presence or absence of infarct pattern LGE did not impact on change in LVEF (men: infarct-LGE(+) 
4.8±7.3 vs. infarct-LGE(-) 0.7±8.0%, p=0.099; women: infarct-LGE(+) 2.6±3.4 vs. infarct-LGE(-) 1.4±7.1%, 
p=0.670) or LVEDVi (men: infarct-LGE(+) 13.4±22.6 vs. infarct-LGE(-) 11.0±19.8ml/m2, p=0.702; 
women: infarct-LGE(+) 3.7±19.4 vs. infarct-LGE(-) 5.8±13.1ml/m2, p=0.726).  
Of the patients with mid-wall fibrosis pattern LGE at baseline, there was a different distribution 
according to sex (Figure 4) but comparable total amounts when expressed as a percentage of LV mass 
(Table 2). Following valve replacement, only women experienced a significant reduction in total 
fibrosis burden both in absolute terms (men 2.3±4.1 to 2.3±4.7g, p=0.412, women 1.3±1.1 to 0.4±0.8g, 
p=0.010) and as a percentage of LV mass (men 1.2±1.8 to 1.6±2.9%, p=0.716, women 1.2±1.1 to 
0.5±0.9%, p=0.026). The presence (MF(+)) or absence of MF (MF(-)) did not impact on change in LVEF 
(men: MF(+) 1.2±9.3 vs. MF(-) 2.6±6.5%, p=0.292; women: MF(+) 2.4±9.3 vs. MF(-) 1.2±3.9%, p=0.767), 
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LVEDVi (men: MF(+) 13.5±19.4 vs. MF(-) 12.1±21.0ml/m2, p=0.823; women: MF(+) 13.4±19.4  vs. MF(-) 
12.1±21.0ml/m2, p=0.053) or LVMi (men: MF(+) -17.7±10.0 vs. MF(-) -19.4±11.6g/m2, p=0.936; women: 
MF(+) -14.7±6.8 vs. MF(-) -11.8±9.9 vs. -14.7±6.8g/m2, p=0.311). 
 
Figure 4. The distribution and frequency of focal mid-wall MF for 28 men and 16 women with severe 
AS as represented using the 17-segment American Heart Association (AHA) model. Focal fibrosis was 
greatest in the basal and septal regions in men (arrow) whereas women appeared to have a more 
varied distribution. The shaded diagram represents the proportion of patients with fibrosis in each 
numbered segment; <4% white, 4-8% light grey, 8-12% dark grey, >12% black.  
 
Predictors of reverse remodeling 
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Clinical variables including patient demographics, co-morbidities and pre-operative cardiac 
measurements were analysed to determine predictors of reverse remodeling. These variables were 
each used as dependent variables in linear regression analysis.  Results of the univariate analysis can 
be seen in Supplementary Table 1. For every dependent variable, the baseline level of the same 
measure emerged as the main predictor in a multivariable model. The relationship between each 
dependent and its baseline level is shown in Figure 5. Sex was only implicated as a factor for left atrial 
reverse remodeling but did not appear to influence LV reverse remodeling, and its inclusion in the 
multivariable model had minimal impact on the parameter estimates for the relevant baseline.  
Procedure type or the presence of coronary artery disease did not appear to predict reverse 
remodeling on univariate analysis. Baseline aortic regurgitation fraction was an independent predictor 
of change in LVMi alongside baseline LVMi, but was not an independent predictor in the multivariate 
model for any other reverse remodelling parameter. Results of the multiple regression analysis can be 
seen in Supplementary Table 2.  
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Figure 5. Relationship between cardiac reverse remodeling parameters following aortic valve 
replacement and baseline parameters displayed according to sex. A. Relationship between change in 
indexed LV mass (LVMi) and baseline LVMi. B. Relationship between change in indexed LV end 
diastolic volume (LVEDVi) and baseline LVEDVi. C. Relationship between change in LV ejection 
fraction (LVEF) and baseline LVEF. D. Relationship between change in indexed left atrial volume 
(LAVoli) and baseline LAVoli. E. Relationship between change in indexed left ventricular end systolic 
volume (LVESVi) and baseline LVESVi.  
DISCUSSION 
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This study is the first using the reference standard of CMR to accurately assess the influence of sex on 
differences in LV remodeling in AS and the impact on reverse remodeling following AVR.   
Our baseline CMR results demonstrating differing patterns of ventricular remodeling in response to 
AS are consistent with the published echocardiographic and CMR literature11, 12, 22. We have 
demonstrated that men and women with severe AS and similar co-morbidities remodel in different 
ways; women exhibit lower LV mass with a smaller LV cavity size, whereas men are prone to the 
development of a larger cavity size, greater LV wall thickness and increased LV mass. This pattern of 
remodeling is seen despite similar valvular gradients between groups but may be in part related to 
differing degrees of baseline aortic regurgitation. Hormonal influences may also be involved, with 
oestrogen limiting hypertrophy up to the menopause and its subsequent lack leading to accelerated 
(and possibly therefore different) patterns of hypertrophy in post-menopausal women compared to 
men23.  
In contrast to other studies evaluating sex in AS, our male and female groups were similar in terms of 
co-morbidity, cardiac risk score, NYHA classification and echo derived valve gradients. Only age, 
baseline aortic regurgitation and, expectedly, coronary artery disease prevalence and body size 
differed between the two groups. Previous reports of referral bias for men over women are seen again 
in our population, with male sex accounting for 74% of the SAVR population7. In our study, men and 
women had similar reverse remodeling 6 months following valve replacement. Multiple regression 
analysis suggested that the main predictor of reverse remodeling for each category was the baseline 
level of that variable. So, the greater absolute LV mass regression seen in men was a result of the fact 
that men have more LV mass at baseline than their female counterparts, rather than a sex-related 
difference per se.  Stangl et al found a better LVEF at baseline and a more favourable LV remodeling 
response in women upon serial echocardiography following TAVR, but their female population had 
higher pre-TAVR aortic valve gradients than men, which may explain the greater degree of mass 
regression seen13.In an echocardiographically based study of 92 patients undergoing SAVR for isolated 
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AS,  Petrov et al 14 found a similar LVMi at baseline in men and women, but a greater degree of LVM 
regression in women after SAVR. This study was based on measurements taken only 3 days post-SAVR. 
The change in LVM reported was a reflection of a change in cavity size rather than a change in wall 
thickness, and it could be that the LVM regression reported was actually a reflection of the 
mathematical assumptions made by the echocardiographic estimation of LVM. Our study provides 
more robust data than that of Petrov et al; CMR is a well validated and accurate technique for LVM 
quantification, which does not rely to the same extent on mathematical assumptions and is 
independent of any change in cardiac geometry which may take place in the peri-operative period. 
Furthermore, the follow up of 6m (rather than 3 days), our larger sample size and the inclusion of 
other parameters of hypertrophy assessment in our study such as wall thickness, means that more 
robust conclusions about sex-related differences in reverse remodeling can be drawn.  
AR has previously been suggested as a modulator of reverse remodeling following valve replacement 
and has been proposed as a mechanism for less favourable outcomes in men in the TAVR literature24.  
In our study, men had more AR at baseline which may in part contribute to their increased LV cavity 
size and mass pre-intervention. The AR regurgitant fraction following valve replacement was similar 
between sexes which may explain why our findings differ from those of Stangl et al where rates of 
residual AR were much higher in men than women13.  A significant reduction in valve gradients was 
observed in both sexes, with no significant difference in CMR derived peak valve gradient according 
to sex, suggesting that patient prosthesis mismatch was not an implicating factor in remodeling 
parameters according to sex.  Furthermore, post-procedure valve gradient was not associated with 
change in LVMi on univariate analysis. A reduction in mitral regurgitation was seen in men but not 
women. This, alongside the reduction in left atrial size seen in men but not women, may reflect a 
greater improvement in left ventricular cavity pressure, trans-mitral gradient and mitral valve 
tethering forces in men.    
Myocardial Fibrosis 
20 
 
Myocardial fibrosis has been implicated in adverse clinical outcomes following both TAVR and SAVR25, 
26. Men and women had similar levels of MF at baseline, in keeping with findings from previous 
studies27, 28 but differing distributions. Our study shows that females develop a varied pattern of MF 
whereas men display most fibrosis in the basal and septal regions, suggesting that the pathogenesis 
may differ. The proportion of patients with MF was in keeping with those reported in previous studies; 
Rudolph et al29 investigated 21 patients with AS and found MF in 62% once infarct pattern LGE had 
been excluded.  Our absolute values for MF were lower than in previously reported studies25, 29, 
however, these studies used different methods of MF quantification which most likely accounts for 
the increased values reported, rather than a true difference in absolute levels of MF.  
Following AVR, there was a significant reduction in absolute MF and also MF as a proportion of LV 
mass in women but not in men. This finding is surprising given the greater degree of absolute LV mass 
reduction in the male cohort. Further studies exploring sex differences in MF are required to explain 
this finding. It is possible that the MF regression is different according to sex, with the more varied 
distribution  ?ĨĞŵĂůĞ ? ƉĂƚƚĞƌŶ ƐŚŽǁŝŶŐ Ăn early tendency to regress.. It is also possible that the 
regression in females is a reflection of the fact that more females underwent trans-catheter rather 
than surgical valve replacement, as it has previously been suggested that MF regression is seen 
following TAVR but not SAVR15.  Failure of MF regression following AVR has been reported previously; 
Weidemann et al found no fibrosis regression following SAVR and also reported LV mass regression 
regardless of MF or MF burden28.  Moreover, in our study the MF burden accounted for a very small 
proportion of total LV mass at both baseline and follow up, so one may not expect such a small amount 
of fibrosis to impact significantly on reverse remodeling. 
Limitations 
Patients in the two groups were similarly matched in terms of co-morbidities and clinical 
characteristics but were not comparable in terms of age. Due to age and referral patterns, the 
proportions of each sex undergoing TAVR and SAVR were different hampering any direct comparison 
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between the procedures. Due to their differing implant techniques and flow dynamics, there may be 
important differences between remodeling parameters in SAVR and TAVR, however, the procedure 
type did not influence reverse remodeling on univariate analysis. There was numerically (but not 
statistically significant) greater post-procedural AR in those undergoing TAVR compared with SAVR 
and therefore it is possible that this influenced findings given the different proportion of men and 
women undergoing each procedure. A quarter (26%) of the study population did not complete the 
study protocol, mainly due to permanent pacemaker implantation, which may have introduced bias, 
although the analysed population did not differ in terms of baseline characteristics from the original 
population. The post-procedure scan occurred 6m  following valve replacement; although it is well 
documented that the majority of reverse remodeling occurs within the first 6m30, this could still be 
too early to detect any subtle differences between the sexes. The follow up may also be too short to 
demonstrate reversal of MF. Caution may need to be exercised in the interpretation of mitral 
regurgitation pre-intervention. Mitral regurgitant fraction in the context of severe AS may be 
overestimated using CMR phase contrast imaging due to underestimation of aortic forward flow when 
sampling high velocities 31. Any inferences related to MF are restrained to the technique of LGE 
imaging with its limited spatial resolution and variable inter-scan reproducibility. Our inter and intra-
observer variability were in keeping with the published literature, supporting the notion that the MF 
findings are genuine, however, we accept that this is is a valid limitation of any paper reporting 
quantification of MF mass. T1 mapping is superior at detecting the often diffuse fibrosis seen in the 
pressure overloaded ventricle.  T1 mapping was not widely performed at the time of the study design 
and absolute T1 values can vary between vendors, software release, pulse sequence and contrast 
agent making comparisons difficult in multivendor studies. This study was not designed as a clinical 
outcomes trial, but larger-scale mortality data would be useful to identify any independent prognostic 
markers between the sexes. 
CONCLUSION 
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This study using the reference standard technique of CMR demonstrates that there are clear 
differences in the way that male and female hearts adapt to the pressure overload of AS. Despite 
similar co-morbidities and valvular gradients, women exhibit a lower indexed LV mass and smaller LV 
cavity size than men with a similar burden, but differing patterns of MF. Six months following surgical 
and trans-catheter aortic valve replacement, there are no sex-related differences per se, but superior 
reverse remodeling in men as a result of their more adverse remodeling at baseline.  
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